Cardiorenal Disease Pathways and Treatment of Patients With Comorbid Heart Failure and Chronic Kidney Disease

This publication has 18 references indexed in Scilit:

• Management of Patients with Heart Failure at High Risk of Hyperkalaemia: The CARE-HK in HF Registry
  European Journal of Heart Failure, 2025
• Multidisciplinary approach to patients with heart failure and kidney disease: preliminary experience of an integrated cardiorenal unit
  Clinical Kidney Journal, 2023
• Hyperkalaemia as a Cause of Undertreatment with Mineralocorticoid Receptor Antagonists in Heart Failure
  ESC Heart Failure, 2022
• Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation
  JACC: Heart Failure, 2022
• Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center
  Drugs - Real World Outcomes, 2022
• Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study ( US , UK and Sweden)
  European Journal of Heart Failure, 2021
• Management and Outcomes of Heart Failure Patients with CKD: Experience from an Inter-Disciplinary Clinic
  ESC Heart Failure, 2020
• Sex-Related Differences in Therapeutic Response to Mineralocorticoid Receptor Antagonists in Heart Failure: Summarizing Trial Evidence
  European Journal of Heart Failure, 2020
• Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction
  JACC, 2019
• Cardiorenal Syndrome
  JACC, 2008